Inbrija (levodopa) is used to treat "off" episodes (periods when your medications are wearing off so your Parkinson's symptoms come back) in people with Parkinson's disease (PD). It comes as an inhaler that can be used as needed up to 5 times per day, but it can cause cough and darken your spit, saliva, and sweat.
Inbrija (levodopa) is an anti-Parkinson medication. Parkinson's disease (PD) is caused by low dopamine levels in the brain. Inbrija (levodopa) is a dopamine replacement that crosses into your brain, where it's converted into dopamine. This is believed to raise your dopamine levels and relieve your PD symptoms.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Inbrija (levodopa) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Levodopa, which is the main ingredient in Inbrija (levodopa), can make you fall asleep out of nowhere, even if you don't feel sleepy. This can happen more than one year after you start using Inbrija (levodopa). Because of this risk, avoid driving or doing things that require you to focus until you know how this medication affects you, especially if you normally feel sleepy or if you take other medications that make you drowsy. Let your provider know if you feel very sleepy during the daytime or if you fall asleep during normal daily activities, like eating or having a conversation.
Although rare, stopping Inbrija (levodopa) or lowering your dose suddenly can cause side effects similar to those of neuroleptic malignant syndrome (NMS). This is a life-threatening condition that's caused by certain mental health medications. It can cause very high fevers, confusion, irregular pulse, muscle stiffness, and changes in blood pressure. NMS is treatable if it's recognized early. Don't stop taking Inbrija (levodopa) or lower your dose without talking to your provider, so they can instruct you on how to stop the medication safely.
Inbrija (levodopa) can cause hallucinations and changes in behavior and thinking, such as paranoia, delusions, confusion, aggressive behavior, trouble sleeping, lots of dreaming, and less awareness of your surroundings. Because of this risk, you shouldn't take Inbrija (levodopa) if you have certain mental health conditions. Certain mental health medications, such as haloperidol or risperidone (Risperdal), can worsen your Parkinson's disease and might affect how well Inbrija (levodopa) works.
Inbrija (levodopa) can cause changes in people's behavior, including strong sexual or gambling urges, urges to spend a lot money, and binge eating. This medication can also make it hard to control these urges. If these urges start to have a negative impact on your life, let your provider know. They might have you stop taking the medication.
If you have asthma, COPD, or another lung condition, using Inbrija (levodopa) can make it more difficult for you to breathe. Because of this risk, you shouldn't take Inbrija (levodopa) if you have any lung conditions. If you experience trouble breathing or wheezing while using this medication, contact your provider or get medical help right away.
Inbrija (levodopa) can raise the pressure in your eye if you have glaucoma. Your provider might check your eyes while you're using Inbrija (levodopa).
The typical dose is 84 mg (two 42 mg capsules) inhaled by mouth as needed for "off" episodes, up to 5 times per day. Don't take more than 84 mg (two 42 mg capsules) per "off" episode, and don't use more than 420 mg (5 doses) per day.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Inbrija (levodopa) will not be safe for you to take.
Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.Health conditions
Medications & treatment
Access & affordability
Resources
Yes, the recommended dose is 84 mg total, which means you need to inhale two 42 mg capsules in order to get the full dose. But, each capsule needs to be inhaled one at a time, one right after another, and you shouldn't remove the capsule from the foil packaging until just before using it.
If there's powder left in your inhaler, use a dry tissue or cotton swab to wipe the inside and outside of the mouthpiece, including the mouthpiece holes. This can help prevent powder from building up in the inhaler. No other parts of the inhaler need to be cleaned, and you shouldn't rinse the inhaler or get it wet.
In studies, Inbrija started to work in as soon as 10 minutes but this can vary from person to person.
Yes, you can use Inbrija to treat your PD symptoms in the morning. In studies, participants used Inbrija right after they took their first dose of carbidopa / levodopa (e.g., Sinemet, Rytary) for the day.